Kymab

2 results

Kymab’s main product is a potential treatment for eczema that is going through clinical trials. Photograph: iStock

One of Dublin-listed life science investment company Malin’s key holdings has signalled it plans to float on the stock market in the US. Biopharmaceu(...)

Ian Curley and other executives are  due to present details of the group’s review at a capital markets day in London early next month

Dublin-listed life sciences investment firm Malin has announced the departure of chief executive Adrian Howd after just one year in the post. The tro(...)